Executive bodies

Board of Management

The Supervisory Board resolved on March 23, 2026 to terminate Dr. Abdurazak Mudesir’s position as the Board member responsible for the Product and Technology Board department and to approve his termination agreement effective midnight on March 31, 2026. Dr. Christian Illek is temporarily assuming Dr. Mudesir’s duties alongside his role as Chief Financial Officer until a successor is found.